Purpose
to develop an IPV vaccine adjuvanted with CAF01 that is able to promote significant dose-sparing and enhance mucosal immunity.
Grantee
Division
Global Health
Date
OCTOBER 2012
Region served
GLOBAL
Committed amount
$158,739
Grant topic
Discovery and Translational Sciences
Duration (months)
28
Grantee location
Copenhagen S., Denmark
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.